Showing results (61-70 of 107) with videos related to

Sort By:
Pageof 11
Nutrition and Cancer|January 1, 1986
Diurnal variations in prolactin and growth hormone levels in normal premenopausal vegetarian and omnivorous womenI S Fentiman, M Caleffi, D Y Wang, et al.
Alimentary Pharmacology & Therapeutics|August 1, 1989
Quadruple antimycobacterial chemotherapy in Crohn's disease: results at 9 months of a pilot study in 20 patientsS J Hampson, M C Parker, S H Saverymuttu, et al.
The British Journal of Radiology|January 19, 2012
Prostatic cancer surveillance following whole-gland high-intensity focused ultrasound: comparison of MRI and prostate-specific antigen for detection of residual or recurrent diseaseS Punwani, M Emberton, M Walkden, et al.
Prostate Cancer and Prostatic Diseases|March 14, 2007
Point-of-care PSA testing: an evaluation of PSAwatchO Karim, A Rao, M Emberton, et al.
BJU International|March 5, 2003
The fear of prostate cancer in men with lower urinary tract symptoms: should symptomatic men be screened?C T Brown, E O'Flynn, J Van Der Meulen, et al.
World Journal of Urology|October 15, 2013
Role of focal salvage ablative therapy in localised radiorecurrent prostate cancerA Kanthabalan, M Arya, S Punwani, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 3, 2020
What to expect from a non-suspicious prostate MRI? A reviewG Fiard, J M Norris, T A Nguyen, et al.
The Journal of Urology|January 13, 2006
Age, comorbidity and hypertensive co-medication do not affect cardiovascular tolerability of 10 mg alfuzosin once dailyR Hartung, H Matzkin, A Alcaraz, et al.
Der Urologe. Ausg. A|February 19, 2015
[Focal therapy for prostate cancer: German version]V Kasivisvanathan, T T Shah, I Donaldson, et al.
Lancet (London, England)|January 14, 1989
DNA probes demonstrate a single highly conserved strain of Mycobacterium avium infecting AIDS patientsS J Hampson, F Portaels, J Thompson, et al.
Pageof 11